SHANGHAI FUDAN-ZHANGJIAN BIO-PHARM financial statements, including revenue, expenses, profit, and loss
The total revenue of 1349 for the last quarter is 159.25 M HKD, and it's 4.28% higher compared to the previous quarter. The net income of Q1 24 is 2.55 M HKD.